Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia

NCT03838484 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT03838484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03838484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia
Lead sponsor
Vanderbilt University Medical Center
Phase
Not applicable
Overall status
Terminated
Start date
May 10, 2019
Completion date
February 24, 2020
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

impulsive behavior, schizophrenia